Anaemia is a common complication of chronic kidney disease. The most important contributory factor is an abnormally low circulating concentration of erythropoietin, which is produced by the kidney peritubular cells. Anaemia of kidney disease is likely to develop once the glomerular filtration rate (GFR...
Anemia is common in children with chronic kidney disease (CKD), and the prevalence of this comorbidity increases with advancing CKD stage, affecting nearly all children treated with chronic dialysis. The primary causes of anemia in CKD are erythropoietin (EPO) deficiency/dysregulation, and iron defic...
Chronic kidney disease (CKD) encompasses the full continuum of renal insufficiency and often goes undetected for months, even years. Patients with CKD may go on to develop end-stage renal disease (ESRD), at which point renal replacement therapy — dialysis or transplantation — becomes necessary t...
Mortality and target haemoglobin concentrations in anaemic patients with chronic kidney disease treated with erythropoietin: a meta-analysis. To target higher haemoglobin concentrations when treating patients with anaemia caused by chronic kidney disease with recombinant human erythropoietin puts... A Phrommin...
Aplastic anaemia as a consequence of use of traditional African herbal remedies in Zambia is reported in 5 cases. Three patients died. A feature of the hae... MN Lowenthal,IG Jones,M Desai - 《Journal of Tropical Medicine & Hygiene》 被引量: 25发表: 1978年 Prevalence of Malaria and Anemi...
Results Age was 69 ± 13 years and GFR 27.5 ± 10.0 mL/min/1.73 m2; male gender, diabetes and prior cardiovascular disease were 57.2, 30.1 and 30.1%, respectively. Prevalence of severe and mild anaemia was 18.0 and 44.0% at baseline and remained unchanged at Month 6 (19.3 and 43.2%)....
anemia, anaemia 1. a lack of blood in the body. 2. a low proportion of red cells in the blood. —anemic, anaemic,adj. See also:Disease and Illness -Ologies & -Isms. Copyright 2008 The Gale Group, Inc. All rights reserved.
Kidney Disease: Improving Global Outcomes guidelines on anaemia management in chronic kidney disease: A European Renal Best Practice position statement Recently, the Kidney Disease: Improving Global Outcomes (KDIGO) group has produced comprehensive clinical practice guidelines for the management of anaemia....
Recently, the Kidney Disease: Improving Global Outcomes (KDIGO) group has produced comprehensive clinical practice guidelines for the management of anaemia in CKD patients. These guidelines addressed all of the important points related to anaemia management in CKD patients, including therapy with erythro...
Introduction Hepcidin appears to be an emerging biomarker for anaemia in kidney damage in Chronic Kidney Disease (CKD). Aim: To evaluate serum hepcidin level for its potential role in anaemia of CKD. Materials and Methods: A cross-sectional study was done in 60 subjects. Out of 60 subjects,...